Zoetis Inc (ZTS)
Zoetis Inc. is a U.S.-listed common equity security representing the animal health company Zoetis Inc., which is traded on the NYSE under the symbol ZTS. The company develops, manufactures, and commercializes a broad range of animal health products and related solutions, including medicines, vaccines, diagnostics, biodevices, genetic tests, and precision animal health tools. Its business serves both companion animals such as dogs, cats, and horses, and livestock species including cattle, swine, poultry, fish, and sheep. Zoetis also sells parasiticides, dermatology products, anti-infectives, pain and sedation treatments, nutritionals, and diagnostic products and services. Its customer base includes veterinarians, livestock producers, and pet owners. Founded in 2012, the company is headquartered in Parsippany, New Jersey, and has also worked with Blacksmith Medicines, Inc. on antibiotic discovery for animal health.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Payment Date | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-ZTS
|
$116.32
|
43.6% Upside
|
Undervalued
|
$93
|
14.8% Upside
|
Fair
|
Great
|
December 1, 2026
|
2.6%
|
November 5, 2026
|
12.7x
|
10.6x
|
3.5x
|
33.484 B
|
41.063 B
|
21.7%
|
99.8%
|
5.8
|
33.7%
|
87.8%
|
